INS and metabolic dysfunction-associated steatotic liver disease: The protein also transduces signaling to mediate its role in inflammation33, lipid metabolism, and insulin responsiveness, contributing to the pathogenesis of metabolic diseases, such as obesity, atherosclerosis, NAFLD, and type 2 diabetes34.